首页> 外文期刊>Science >Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
【24h】

Topological control of cytokine receptor signaling induces differential effects in hematopoiesis

机译:细胞因子受体信号传导的拓扑控制诱导造血作用的差异

获取原文
获取原文并翻译 | 示例
       

摘要

Although tunable signaling by G protein-coupled receptors can be exploited through medicinal chemistry, a comparable pharmacological approach has been lacking for the modulation of signaling through dimeric receptors, such as those for cytokines. We present a strategy to modulate cytokine receptor signaling output by use of a series of designed C2-symmetric cytokine mimetics, based on the designed ankyrin repeat protein (DARPin) scaffold, that can systematically control erythropoietin receptor (EpoR) dimerization orientation and distance between monomers. We sampled a range of EpoR geometries by varying intermonomer angle and distance, corroborated by several ligand-EpoRcomplex crystal structures. Across the range, we observed full, partial, and biased agonism as well as stage-selective effects on hematopoiesis. This surrogate ligand strategy opens access to pharmacological modulation of therapeutically important cytokine and growth factor receptor systems.
机译:尽管可以通过药物化学利用G蛋白偶联受体的可调信号传导,但仍缺乏可比较的药理学方法来调节通过二聚体受体,例如细胞因子的信号传导。我们提出了一种策略,通过使用一系列设计的C2对称细胞因子模拟物,基于设计的锚蛋白重复蛋白(DARPin)支架,来调节细胞因子受体信号输出,该策略可以系统地控制促红细胞生成素受体(EpoR)二聚化方向和单体之间的距离。我们通过改变单体角度和距离来采样一系列EpoR几何形状,并证实了几种配体-EpoRcomplex晶体结构。在整个范围内,我们观察到完全,部分和偏向的激动作用以及对造血作用的阶段选择性作用。这种替代配体策略为治疗上重要的细胞因子和生长因子受体系统提供了药理学调节途径。

著录项

  • 来源
    《Science》 |2019年第6442期|750-750|共1页
  • 作者单位

    Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA;

    Univ Washington, Dept Biochem, Seattle, WA 98195 USA|Univ Washington, Inst Prot Design, Seattle, WA 98195 USA;

    Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol Oncol, Boston, MA 02115 USA|Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA|Broad Inst MIT & Harvard, Cambridge, MA 02142 USA;

    Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA;

    Univ Washington, Dept Biochem, Seattle, WA 98195 USA|Univ Washington, Inst Prot Design, Seattle, WA 98195 USA;

    Nankai Univ, State Key Lab Med Chem Biol, Tianjin, Peoples R China|Nankai Univ, Coll Pharm, Tianjin, Peoples R China;

    Univ Osnabruck, Div Biophys, Dept Biol, D-49076 Osnabruck, Germany;

    Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA;

    Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA|Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA;

    Univ Osnabruck, Div Biophys, Dept Biol, D-49076 Osnabruck, Germany|Univ Osnabruck, Ctr Cellular Nanoanalyt, D-49076 Osnabruck, Germany;

    Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Hematol Oncol, Boston, MA 02115 USA|Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA|Broad Inst MIT & Harvard, Cambridge, MA 02142 USA;

    Univ Washington, Dept Biochem, Seattle, WA 98195 USA|Univ Washington, Inst Prot Design, Seattle, WA 98195 USA|Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA;

    Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA|Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA|Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 04:17:37

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号